NCT05139238View on ClinicalTrials.gov

Postpartum Hypertension Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Postpartum Pregnancy-Induced HypertensionPostpartum PreeclampsiaPregnancy-Induced Hypertension in PostpartumHypertensive Emergency
Interventions
DRUG

Labetalol

Intravenous labetalol, a short acting ant-hypertensive

DRUG

Nifedipine

Oral nifedipine, a short acting ant-hypertensive

Trial Locations (1)

10032

RECRUITING

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER